Myocardial Revascularization: Novel Percutaneous Approaches / Edition 1 available in Hardcover
- Pub. Date:
The percutaneous method of transluminal myocardialrevascularization has roused enthusiasm in the field of cardiologybecause it is minimally invasive and relatively inexpensive. In hisprogressive new book, George Abela, a widely recognized pioneer incardiology and lasers, has brought together the expertise ofinternational leaders on the subject in this premier reference,Myocardial Revascularization: Novel Percutaneous Approaches. Thisresource provides interventional cardiologists, technical personneland nurses in cardiac catheterization labs with the most currentscholarly and clinical information available, including:* A historical overview of myocardial revascularization (includingthe Vineberg procedure and the more recent TMR/PMRprocedures)* Biological responses and mechanisms of action in myocardialrevascularization using mechanical, laser, ultrasound, andcryoenergy* Current technology for the percutaneous method of theprocedure* Descriptions of other novel approaches including percutaneous insitu coronary venous arterialization* Discussion of results from preliminary and advanced TMR/PMR incanine and human procedures* Examination of various catheter navigation systems and potentialadjunct gene therapies* Myocyte transplantation to replenish the depletedmyocardium* Insights into the economics of these novel percutaneoustechniques
|Product dimensions:||7.22(w) x 9.98(h) x 0.86(d)|
About the Author
Dr. George S. Abela is currently professor of medicine, Chief of the Cardiology Division and director of the fellowship training program at Michigan State University. Prior to that he was an associate professor of medicine at Harvard Medical School and director of Interventional Research and Cardiovascular Photobiology Laboratory at Deaconess Hospital as well as co-director of the Institute for Prevention of Cardiovascular Disease. He completed his residency and internship in medicine at Emory University and his fellowship in cardiology at the University of Florida. Dr. Abela has a master's degree in cardiovascular pharmacology, an M.D. from the American University of Beirut in Lebanon and an MBA from Michigan State University. He was elected as vice president of the American Society for Lasers in Medicine and Surgery (1993-4) and was the recipient of the Mark B. Award and the Ellet Drake Lectureship Awards. He is a fellow of the American College of Cardiology, a member of the Association of Professors of Cardiology, the American Heart Association, The American Federation for Clinical Research, American College of Physicians, The Central Society of Clinical Research and the Sigma-Xi Scientific Society. He is past recipient of the Young Investigator Award and Research Career Development Award from the National Institutes of Health. Dr. Abela is an internationally recognized pioneer in the development and evaluation of numerous laser systems for the treatment of cardiovascular disease and is actively continuing his research and publications in this area. He was the first investigator in the U.S. to receive FDA approval for using laser angioplasty in the peripheral circulation. Other work has included using laser for ablation of arrhythmia generating foci in the heart, detecting platelet aggregates in circulating fluids and evaluation of the mechanism of transmyocardial revascularization (TMR).
Table of Contents
Foreword.Preface.Contributors.PART I: BACKGROUND OF MYOCARDIAL REVASCULARIZATIONTECHNIQUES.Myocardial Revascularization: The Role of the Vineberg Operationand Related Procedures (O. Topaz).Historical Perspectives and Development of TransmyocardialRevascularization (M. Cayton & M. Mirhoseini).Clinical Efficacy and Experience with Transmyocardial LaserRevascularization (TMR) (K. Horvath).PART II: BIOLOGICAL RESPONSES AND MECHANISMS OF ACTION OFMYOCARDIAL REVASCULARIZATION.Angiogenesis vs. Arteriogenesis: Can Different TransmyocardialRevascularization Approaches be Distinguished (R. Virmani, etal.).Revascularization versus Denervation: What are the Mechanisms ofSymptom Relief? (G. Hughes & J. Lowe).Potential Mechanisms of Myocardial Revascularization Techniques:Channels, Functional and Structural Remodeling, Angiogenesis,Denervation, or Placebo (E. Hage-Korban, et al.).Biosense NOGA(TM): Percutaneous Laser Myocardial Revascularizationand Gene Transfer (M. Foster, et al.).PART III: CURRENT TECHNOLOGY FOR PERCUTANEOUS MYOCARDIALREVASCULARIZATION.Percutaneous Myocardial Revascularization (PMR): Indications andClinical Experience (J. Eisenberg, et al.).Novel Revascularization Strategies: PMR, TMR and Percutaneous insitu Coronary Venous Arterialization (W. Abernethy, et al.).PART IV: OTHER METHODS OF MYOCARDINAL REVASCULARIZATION.Transmyocardial and Percutaneous Myocardial Revascularization:Nonlaser Approaches (B. Kantor, et al.).Cryoenergy-Induced Neovascularization for Myocardial Reperfusion: ANovel Alternative to Percutaneous Myocardial Revascularization (R.Gallo & M. Dubuc).Ultrasonic Surgery: Mechanism of Action and Implications forTransmyocardial Revascularization (R. Verdaasdonk, et al.).Left Ventricular Electromechanical Mapping As a Diagnostic Method(E. Perin, et al.).Percutaneous Gene Therapy for Myocardial Angiogenesis (S.Werns).Myocardial Angiogenesis: Clinical Trial Results (T. Henry & C.Boisjolie).The Coronary Veins as an Alternative Access for Gene Transfer andAngiogenesis by Selective Pressure-Regulated Retroperfusion (P.Boekstegers, et al.).Percutaneous Intrapericardial Drug Delivery for MyocardialAngiogenesis (S. Waxman).Cell Transplantation: Its Application in the Treatment of CardiacDysfunction and its Effect on Angiogenesis (M. Yao & R.Kloner).Percutaneous Myocardial Revascularization: Financial Potential AndMarket Acceptance (T. Woodward, et al.).Glossary.Index.
What People are Saying About This
"The book is the best compendium of the current knowledge of non-conventional means of restoring blood flow to ischemic hearts. For the patient and practitioner who have run out of options this book provides a tremendous reference." (Keith Horvath, M.D., Northwestern University Medical School)